Abstract
Introduction
The purpose of this study was to propose new magnetic resonance (MR) criteria of diagnosing moyamoya disease (MMD) from cisternal moyamoya vessels (MMVs) on 3-T magnetic resonance imaging (MRI)/magnetic resonance angiography (MRA) and compare the diagnostic accuracy of the existing MR criteria and the proposed MR criteria.
Methods
Participants comprised 20 consecutive patients with MMD (4 males, 16 females) diagnosed clinically using conventional angiography and 20 controls (13 male and 7 female arteriosclerosis patients). In these participants, 3-T MRI/MRA was evaluated by the existing MR criteria, which use MMVs in the basal ganglia, and the proposed MR criteria, which use cisternal MMVs, and then these two criteria were statistically compared by McNemar’s test.
Results
Diagnostic accuracy was 62.5% with the existing MR criteria and 97.5% with the proposed MR criteria. The proposed MR criteria was more sensitive (1.00) than the existing MR criteria (0.45), but less specific (0.95) than the existing MR criteria (1.00).
Conclusion
The proposed MR criteria using cisternal MMVs showed significantly higher diagnostic accuracy than the existing MR criteria. We believe that our proposed MR criteria will be beneficial for diagnosing MMD.
Similar content being viewed by others
Abbreviations
- ACA:
-
Anterior cerebral artery
- AUC:
-
Area under the curve
- CSF:
-
Cerebrospinal fluid
- FSE:
-
Fast spin echo
- ICA:
-
Internal carotid artery
- MCA:
-
Middle cerebral artery
- MIP:
-
Maximum intensity projection
- MMD:
-
Moyamoya disease
- MMVs:
-
Moyamoya vessels
- MR:
-
Magnetic resonance
- MRA:
-
Magnetic resonance angiography
- MRI:
-
Magnetic resonance imaging
- ROC:
-
Receiver operating characteristic
- SNR:
-
Signal-to-noise ratio
- SWI:
-
Susceptibility-weighted imaging
- T2WI:
-
T2-weighted imaging
- TOF:
-
Time-of-flight
References
Suzuki J, Takaku A (1969) Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20(3):288–299
Burke GM, Burke AM, Sherma AK, Hurley MC, Batjer HH, Bendok BR (2009) Moyamoya disease: a summary. Neurosurg Focus 26(4):E11. doi:10.3171/2009.1.FOCUS08310
Takahashi JC, Miyamoto S (2010) Moyamoya disease: recent progress and outlook. Neurol Med Chir (Tokyo) 50(9):824–832. doi:JST.JSTAGE/nmc/50.824
Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A, Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M, Miyamoto S, Nagata K, Hashimoto N, Koizumi A (2011) Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 6(7):e22542. doi:10.1371/journal.pone.0022542
Fukui M (1997) Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘moyamoya’ disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99(Suppl 2):S238–S240
Jones BP, Ganesan V, Saunders DE, Chong WK (2010) Imaging in childhood arterial ischaemic stroke. Neuroradiology 52(6):577–589. doi:10.1007/s00234-010-0704-7
Serdaru M, Gray F, Merland JJ, Escourolle R, Grumbach R (1979) Moyamoya disease and intracerebral hematoma. Clinical pathological report. Neuroradiology 18(1):47–52
Currie S, Raghavan A, Batty R, Connolly DJ, Griffiths PD (2011) Childhood moyamoya disease and moyamoya syndrome: a pictorial review. Pediatr Neurol 44(6):401–413. doi:10.1016/j.pediatrneurol.2011.02.007
Takanashi J (2011) Moyamoya disease in children. Brain Dev 33(3):229–234. doi:10.1016/j.braindev.2010.09.003
Lee DJ, Liebeskind DS (2011) Characterization of inpatient moyamoya in the United States: 1988–2004. Front Neurol 2:43. doi:10.3389/fneur.2011.00043
Houkin K, Aoki T, Takahashi A, Abe H (1994) Diagnosis of moyamoya disease with magnetic resonance angiography. Stroke 25(11):2159–2164
Maki Y, Enomoto T (1988) Moyamoya disease. Childs Nerv Syst 4(4):204–212
Tanenbaum LN (2004) 3-T MR imaging: ready for clinical practice. AJNR Am J Neuroradiol 25(9):1626–1627, author reply 1629
Thomas SD, Al-Kwifi O, Emery DJ, Wilman AH (2002) Application of magnetization transfer at 3.0 T in three-dimensional time-of-flight magnetic resonance angiography of the intracranial arteries. J Magn Reson Imaging 15(4):479–483. doi:10.1002/Jmri.10085
Fushimi Y, Miki Y, Kikuta K, Okada T, Kanagaki M, Yamamoto A, Nozaki K, Hashimoto N, Hanakawa T, Fukuyama H, Togashi K (2006) Comparison of 3.0- and 1.5-T three-dimensional time-of-flight MR angiography in moyamoya disease: preliminary experience. Radiology 239(1):232–237. doi:10.1148/radiol.2383042020
Kikuta K, Takagi Y, Nozaki K, Hanakawa T, Okada T, Mikuni N, Miki Y, Fushmi Y, Yamamoto A, Yamada K, Fukuyama H, Hashimoto N (2005) Asymptomatic microbleeds in moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study. J Neurosurg 102(3):470–475. doi:10.3171/jns.2005.102.3.0470
Mori N, Miki Y, Kikuta K, Fushimi Y, Okada T, Urayama S, Sawamoto N, Fukuyama H, Hashimoto N, Togashi K (2008) Microbleeds in moyamoya disease: susceptibility-weighted imaging versus T2*-weighted imaging at 3 Tesla. Invest Radiol 43(8):574–579. doi:10.1097/RLI.0b013e31817fb432
Illner A (2009) Moyamoya. In: Osborn AG, Salzman KL, Barkovich AJ (eds) Diagnostic imaging: brain, 2nd edn. Lippincott Williams & Wilkins, Salt Lake City, pp I-4-46–I-4-49
Maeda M, Tsuchida C (1999) “Ivy sign” on fluid-attenuated inversion-recovery images in childhood moyamoya disease. Am J Neuroradiol 20(10):1836–1838
Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, Marks MP, Steinberg GK (2009) Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg 111(5):927–935. doi:10.3171/2009.4.JNS081649
Hanley JA, Mcneil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148(3):839–843
McNemar Q (1947) Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 12(2):153–157
Fukui M (1997) Current state of study on moyamoya disease in Japan. Surg Neurol 47(2):138–143
Fujisawa I, Asato R, Nishimura K, Togashi K, Itoh K, Noma S, Sagoh T, Minami S, Nakano Y, Yonekawa Y et al (1987) Moyamoya disease: MR imaging. Radiology 164(1):103–105
Yamada I, Matsushima Y, Suzuki S (1992) Moyamoya disease: diagnosis with three-dimensional time-of-flight MR angiography. Radiology 184(3):773–778
Battistella PA, Carollo C, Pellegrino PA, Soriani S, Scarpa P (1995) Magnetic resonance angiography in moyamoya disease. Childs Nerv Syst 11(6):329–334
Houkin K, Nakayama N, Kuroda S, Nonaka T, Shonai T, Yoshimoto T (2005) Novel magnetic resonance angiography stage grading for moyamoya disease. Cerebrovasc Dis 20(5):347–354. doi:10.1159/000087935
Yamada I, Suzuki S, Matsushima Y (1995) Moyamoya disease: diagnostic accuracy of MRI. Neuroradiology 37(5):356–361
Bacigaluppi S, Dehdashti AR, Agid R, Krings T, Tymianski M, Mikulis DJ (2009) The contribution of imaging in diagnosis, preoperative assessment, and follow-up of moyamoya disease: a review. Neurosurg Focus 26(4):E3. doi:10.3171/2009.01.FOCUS08296
Komiyama M, Ishiguro T, Nishikawa M, Yasui T, Morikawa T, Kitano S, Sakamoto H (2002) Constructive interference in steady state imaging of moyamoya disease. Neurol Med Chir (Tokyo) 42(1):11–16, discussion 17
Yao B, Li TQ, van Gelderen P, Shmueli K, de Zwart JA, Duyn JH (2009) Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. Neuroimage 44(4):1259–1266. doi:10.1016/j.neuroimage.2008.10.029
Hallemeier CL, Rich KM, Grubb RL, Chicoine MR, Moran CJ, Cross DT, Zipfel GJ, Dacey RG, Derdeyn CP (2006) Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 37(6):1490–1496. doi:10.1161/01.Str.0000221787.70503.Ca
Kim SK, Seol HJ, Cho BK, Hwang YS, Lee DS, Wang KC (2004) Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment. Neurosurgery 54(4):840–845. doi:10.1227/01.Neu.0000114140.41509.14
Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA (2004) Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 100(2):142–149
Scott RM, Smith ER (2009) Moyamoya disease and moyamoya syndrome. N Engl J Med 360(12):1226–1237. doi:10.1056/NEJMra0804622
Conflict of interest
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sawada, T., Yamamoto, A., Miki, Y. et al. Diagnosis of moyamoya disease using 3-T MRI and MRA: value of cisternal moyamoya vessels. Neuroradiology 54, 1089–1097 (2012). https://doi.org/10.1007/s00234-012-1020-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-012-1020-1